Hologic | HOLX - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Danaher USD 4.62B 3.09B 2025-12
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Fuji Electric JPY 69.37B 14.31B 2025-12
Fujifilm JPY 160.88B 906M 2025-09
General Electric Aerospace USD 12.39B 109M 2025-12
Globus Medical USD 526.16M 154.39M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Illumina USD 1.42B 368M 2025-12
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Medtronic USD 1.15B 135M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
OraSure Technologies USD 199.28M 17.2M 2025-12
Philips EUR 1.91B 90M 2025-09
Quidel USD 169.8M 71.7M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Siemens EUR 14.5B 146M 2025-09
Stryker USD 4.01B 755M 2025-12
Teleflex USD 354M 100.3M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Waters USD 587.83M 128.71M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12